Proteasome inhibition in hematologic malignancies: clinical update and practical applications.
Dalton
William S
WS
D002453:Cell Cycle / Q000187:drug effects; D018849:Controlled Clinical Trials as Topic; D019337:Hematologic Neoplasms / Q000188:drug therapy* / Q000201:enzymology; D006801:Humans; D011480:Protease Inhibitors / Q000627:therapeutic use*; D061988:Proteasome Inhibitors
D011480:Protease Inhibitors; D061988:Proteasome Inhibitors